News

Product tanker owners are again facing a threat from larger crude carriers cleaning up to load refined cargoes. The latest ...
Even the CEOs of Big Pharmas have come under fire. Activist investor Starboard Value has made no secret of its criticism of Pfizer CEO Albert Bourla’s track record, while GSK CEO Emma Walmsley fought ...
Keros Therapeutics, Takeda in Elritercept Licensing Pact Global News Select Dec 3, 2024, 5:49:00 AM ...
Keros potential drug for high blood pressure in lungs KER-012 shows tolerability in healthy people in interim data SA NewsWed, May 18, 2022 ...
Keros Therapeutics, Inc. (KROS) earnings report: revenue, EPS, surprise, history, news and analysis.
MSD’s Winrevair (sotatercept) has become the first FDA-approved therapy for PAH that addresses the underlying mechanism behind the disease, rather than its symptoms.